PHENYL-4,6-DIMETHOXY-2-PYERIMIDYLAMINO FORMATE, 97.0%, 25g

1-(2,6-Diisopropylphenyl)-2-phenyl-1H-imidazole, 95.0%, 100mg

Di-ammonium hydrogen citrate, min. 98%, pa, ACS, 100 g, plastic packaging.

Isoxazole-4-boronic acid, 95.0%, 5g

1-ethylbenzo[cd]indol-2(1H)-one, 95.0%, 250mg

3-Ethynylbenzoic acid methyl ester, 95.0%, 5g

4-Dodecylbenzenesulfonyl azide soft type mixture, 1g

3-(1-Methylpropyl)pyrrolidine, 97%, 5g

2-(Dimethoxymethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 1g

5,7-Dimethylpyrazolo[1,5-a]pyrimidine-2,3-diamine, 95.0%, 1g

1,2,3-Trifluoro-5-[trans-4-[2-(trans-4-propylcyclohexyl)ethyl]cyclohexyl]benzene>98.0%(GC)1g

4,4,5,5-Tetramethyl-2-(2-methylprop-1-en-1-yl)-1,3,2-dioxaborolane, 95.0%, 100g

N4-Benzoylcytidine, 95.0%, 25g